Author

G. Ferri

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1 Microbiology· 1 Pathology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 5 Research Focus:host-pathogen & immune response· 3 Assay:bulk RNA-seq· 2 Organism:human· 2 Organism:mouse· 2 Research Focus:benchmarking· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1

Frequent Co-Authors

A. Viau· 2 shared E. Poree· 2 shared E. W. Kuehn· 2 shared M. M. Edreira· 2 shared M. Quatredeniers· 2 shared S. Braeg· 2 shared S. Saunier· 2 shared A. L. Di Stefano· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

A. Viau

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

BIRC3: A Prognostic Predictor and Novel Therapeutic Target in TMZ-Resistant Glioblastoma Tumors

M. Morelli, S. Franceschi, F. Lessi, P. Aretini, A. Pastore, E. Corradi, A. Marranci, C. Gambacciani, F. Pieri, G. Grimod, N. Montemurro, M. Giacomarra, M. Menicagli, G. Ferri, F. Pasqualetti, , C. M. Mazzanti

This study identifies BIRC3 as a prognostic biomarker and therapeutic target for TMZ-resistant glioblastoma, validated across multiple datasets and showing efficacy when combined with AZD5582.

bioRxiv · Aug 23, 2023 · PreprintCancer Biology

Host cell cAMP-Epac pathway inhibition by hawthorn extract as a potential treatment for Chagas disease

G. Ferri, L. R. Fernandez, G. T. Di Mario, J. A. Palermo, M. M. Edreira

This paper investigates hawthorn extract's effect on the host cell cAMP-Epac pathway, showing it inhibits Trypanosoma cruzi invasion and synergizes with nifurtimox to reduce treatment toxicity and cost.

bioRxiv · Jan 26, 2023 · PreprintMicrobiology

Host Cell Rap1b mediates cAMP-dependent invasion by Trypanosoma cruzi

G. Ferri, M. M. Edreira

The paper identifies Rap1b as a mediator of cAMP-dependent invasion by Trypanosoma cruzi, showing its activation and relocalization during invasion and its regulation by PKA.

bioRxiv · Jun 22, 2022Cell Biology

YAP restricts renal inflammation and mitigates kidney damage in nephronothisis related kidney disease.

G. Ferri, V. Goffette, E. Poree, S. Braeg, S. Carvalho, M. Quatredeniers, E. W. Kuehn, S. Saunier, A. Viau

This study investigates the role of YAP in NPH-like kidney disease and finds that YAP inhibition is not therapeutic, suggesting LKB1 and YAP are parallel regulators of a harmful pathway.

bioRxiv · Jan 17, 2022 · PreprintPathology

The renal inflammatory network of nephronophthisis

M. Quatredeniers, F. Bienaime, G. Ferri, P. Isnard, E. Poree, K. Billot, E. Birgy, S. Ceccarelli, F. Legendre, S. Braeg, T. Nguyen-Khoa, R. Salomon, M.-C. Gubler, E. W. Kuehn, S. Saunier, A. Viau

This study identifies a CCL2-independent inflammatory network in nephronophthisis, revealing distinct immune cell infiltration and cytokine signatures compared to autosomal dominant polycystic kidney disease.

bioRxiv · Jan 7, 2021Physiology